Cite

HARVARD Citation

    Lopez Campos, F. et al. (n.d.). PD-0908 PSA Progression and survival in mCRPC patients treated with abiraterone or enzalutamide. Radiotherapy and oncology. pp. S750-S751. [Online]. 
  
Back to record